Inactivation of the Mouse Huntington's Disease Gene Homolog <i>Hdh</i>

Mabel P. Duyao(Massachusetts General Hospital), Anna B. Auerbach(Mount Sinai Hospital), Angela Ryan(Massachusetts General Hospital), Francesca Persichetti(Massachusetts General Hospital), Glenn T. Barnes(Massachusetts General Hospital), Sandra McNeil(Massachusetts General Hospital), Pei Ge(Massachusetts General Hospital), Jean‐Paul Vonsattel(Massachusetts General Hospital), James F. Gusella(Massachusetts General Hospital), Alexandra L. Joyner(Mount Sinai Hospital), Marcy E. MacDonald(Massachusetts General Hospital)
Science
July 21, 1995
Cited by 725

Abstract

Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.


Related Papers

No related papers found

Powered by citation graph analysis